SCHEMBL9060073

SCHEMBL9060073

CCCCN(C)C(=Nc1ccccc1N1CCOCC1)N(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.43
NPSR1 Q6W5P4 2/20 0.40
ALDH1A1 P00352 6/20 0.39
GAA P10253 3/20 0.38
KDM4E B2RXH2 2/20 0.38
LMNA P02545 2/20 0.36
RECQL P46063 1/20 0.35
NAPEPLD Q6IQ20 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
KCNQ2 O43526 1/20 0.35
TSHR P16473 1/20 0.34
HSD17B10 Q99714 2/20 0.34
NPC1 O15118 1/20 0.34
GLA P06280 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9060069 1.00 SMN1; SMN2 (0.43) SMN1; SMN2NPSR1ALDH1A1GAAKDM4E
SCHEMBL9059295 0.97 SMN1; SMN2 (0.45) SMN1; SMN2NPSR1ALDH1A1GAAKDM4E
SCHEMBL9059292 0.97 SMN1; SMN2 (0.45) SMN1; SMN2NPSR1ALDH1A1GAAKDM4E
SCHEMBL9424739 0.88 SMN1; SMN2 (0.39) SMN1; SMN2NPSR1ALDH1A1GAAKDM4E
SCHEMBL9424742 0.88 SMN1; SMN2 (0.39) SMN1; SMN2NPSR1ALDH1A1GAAKDM4E
SCHEMBL9424037 0.86 SMN1; SMN2 (0.43) SMN1; SMN2NPSR1ALDH1A1GAAKDM4E
SCHEMBL9424041 0.86 SMN1; SMN2 (0.43) SMN1; SMN2NPSR1ALDH1A1GAAKDM4E
SCHEMBL9060399 0.85 ALOX15 (0.41) SMN1; SMN2NPSR1ALDH1A1GAAKDM4E
Iodide SCHEMBL9424454 0.84 ALOX15 (0.40) SMN1; SMN2NPSR1ALDH1A1GAAKDM4E
SCHEMBL9059175 0.81 ALOX15 (0.36) SMN1; SMN2NPSR1ALDH1A1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 WO disclosed
US-5373008-A Phenylamidine and phenylguanidine derivatives and their use as anti-diabetic agents THE BOOTS COMPANT PLC. (GB) 1994-12-13 US disclosed
US-5223498-A Hypoglycemic agents THE BOOTS COMPANY PLC (GB) 1993-06-29 US disclosed
EP-0385038-B1 ORTHO-SUBSTITUTED PHENYL AMIDINE AND PHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM The Boots Company PLC (GB) 1993-06-02 EP disclosed
EP-0385038-A1 Ortho-substituted phenyl amidine and phenyl guanidine derivatives and antidiabetic or hypoglycaemic agents containing them The Boots Company PLC (GB) 1990-09-05 EP disclosed